Nanjing Well Pharmaceutical Group Co.,Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd.

603351.SS
Nanjing Well Pharmaceutical Group Co.,Ltd.CN flagShanghai
24.10
CNY
+0.46
(+1.95%)
1.08EPS
22.31P/E
3.26BMarket Cap
May 16Next Earn

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) Stock Splits

Learn about Nanjing Well Pharmaceutical Group Co.,Ltd.'s most recent 7-for-5 basis stock split on May 27, 2020. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Nanjing Well Pharmaceutical Group Co.,Ltd.'s most recent stock split

Split Date: 2020-05-27
Split Ratio: 7:5
Price Before Split: $33.84
Price After Split: $24.17

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.40 times more shares (a 7:5 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Nanjing Well Pharmaceutical Group Co.,Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2020-05-277:5No$33.84$24.17
2019-05-287:5No$50.94$36.39

About Nanjing Well Pharmaceutical Group Co.,Ltd.

Company overview and industry information

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 7-for-5 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Nanjing Well Pharmaceutical Group Co.,Ltd. Summary

Last updated: 2/10/2025

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.